Leave Your Message
Explore our core biological, probiotic, and pharmaceutical solutions tailored to stabilize fluid levels, enhance gut immunity, and combat dehydration-induced stress in young animals.
In veterinary medicine, neonatal and pediatric animals (such as newborn calves, piglets, lambs, and foals) represent the most vulnerable demographic. Unlike mature livestock, neonates possess a significantly higher body water percentage (up to 75-80% of body weight compared to 60% in adults) and a much larger surface-area-to-body-mass ratio. Consequently, fluid loss due to environmental stress, pathogenic diarrhea (scours), or poor nursing can lead to rapid, life-threatening dehydration and metabolic acidosis within hours.
Neonates have a metabolic rate and water turnover rate up to three times higher than adults, making them highly sensitive to even minor disruptions in fluid intake.
Immature immune systems leave young animals open to pathogens like Rotavirus, Coronavirus, E. coli, and Cryptosporidium, which destroy intestinal villi and cause severe osmotic diarrhea.
Dehydration triggers anaerobic metabolism, causing lactic acid buildup. Effective hydration therapy must restore blood volume and buffer blood pH simultaneously.
Hydration therapy is not merely about administering water; it is a complex physiological intervention. Proper therapy requires balancing osmotic pressure, restoring extracellular fluid volume, supplying essential electrolytes (sodium, potassium, chloride), and providing rapid-energy substrates like dextrose to maintain cellular metabolism. Additionally, supporting the gut mucosal barrier is crucial to prevent systemic translocation of bacteria.
The global market for animal health products, specifically targeting pediatric and neonatal hydration, is undergoing a paradigm shift. Historically, treatment was reactive, consisting of basic saline solutions administered when animals were already recumbent. Today, the industry focuses on proactive, high-efficiency formulation technologies that minimize mortality and reduce the need for antibiotic interventions.
Key commercial trends driving the industry include:
As global livestock farming intensive practices expand, the economic impact of neonatal mortality becomes more pronounced. A single calf lost to scours represents a direct capital loss and affects the long-term genetic potential of the herd. Consequently, veterinary pharmaceutical manufacturers are investing heavily in high-performance hydration therapies that are easy to administer, highly palatable, and stable under variable farm storage conditions.
Understanding the specific clinical environments where pediatric and neonatal hydration products are deployed helps optimize product selection and formulation strategies.
In dairy and beef operations, diarrheal diseases are the leading cause of calf mortality. Oral rehydration solutions containing sodium bicarbonate or acetate act as critical alkalizing agents, correcting systemic acidosis and restoring vigor so calves can continue drinking milk.
Weaning is a highly stressful event for piglets, characterized by a sudden change in diet and environment. This stress often leads to starvation and dehydration. Administering electrolyte-rich hydration solutions with probiotics helps maintain gut integrity and prevents post-weaning diarrhea.
Neonatal foals suffering from septicemia, neonatal maladjustment syndrome, or enterocolitis require rapid, precise fluid therapy. Veterinary hospitals utilize specialized intravenous and oral hydration formulations, combined with targeted APIs, to stabilize cardiovascular volume.
By utilizing targeted APIs and nutritional additives—such as high-potency probiotics to colonize the gut, or selective antiparasitics like Doramectin to eliminate underlying pathogen loads—livestock managers can execute a comprehensive therapy program that addresses both the symptoms (dehydration) and the root causes (infection and dysbiosis) of neonatal diseases.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our products meet international quality standards and are widely used in both human and animal health industries. With our deep technical expertise and strict quality control processes, we ensure that every batch of raw materials and finished products we supply supports the optimal health of the target species, especially in critical applications like pediatric and neonatal animal care.
Read more
At Jiangxi Serum Pharma, we bridge the gap between advanced scientific research and practical animal health applications. Our comprehensive portfolio is divided into two primary segments designed to support animal vitality, hydration, and disease recovery.
OUR PREMIUM PRODUCTS WILL BRING BACK THE HEALTH. Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices. These products are crucial for setting up effective clinical protocols for treating infectious diseases that cause severe dehydration in young livestock.
View DetailsDERIVES FROM THE NATURE TO MAINTAIN BODY HEALTH AND BALANCE WITH PURITY. Our nutritional ingredients cover several categories as plant extracts, plant oils & proteins, probiotics and other specialties. We are committed to exploring more health ingredients to support animal health, stabilize gut microbiota, and enhance the efficacy of oral hydration therapies.
View DetailsSerum Pharma continuously monitors the development of cutting-edge markets. Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization, and Bio-Fermentation products service, and have launched corresponding support services to meet the complex formulation needs of modern veterinary medicine.
Customized homogenous mixtures of vitamins, minerals, and micro-ingredients designed to simplify feed production and ensure precise nutrient distribution in neonatal diets.
Read More
Innovative technology to combine active drug substances with carrier materials, improving solubility, bioavailability, and taste-masking for oral hydration powders.
Read More
Leveraging high-yield microbial processes to produce pure probiotics, enzymes, and organic acids that support gut health and fluid absorption in young animals.
Read MoreStay updated with the latest research, market analyses, and pharmaceutical breakthroughs from Jiangxi Serum Pharma.
An in-depth analysis of the growing global demand for plant-derived squalene, its applications in vaccine adjuvants, and how sustainable extraction methods are shaping the future of biopharmaceuticals.
Exploring the therapeutic importance of Dexamethasone Sodium Phosphate. As a powerful anti-inflammatory agent, it plays a vital role in managing severe inflammatory responses, shock, and respiratory distress in both human and veterinary critical care.
A major milestone in obesity treatment: Lilly's oral small-molecule GLP1 drug has been approved with a rapid 50-day approval process. Featuring no fasting requirements or water restrictions, it offers unprecedented flexibility and compliance for patients worldwide.
Browse our complete selection of high-quality APIs, probiotics, and pharmaceutical formulations optimized to support livestock vitality, immune response, and hydration management.
Contact us today to receive detailed technical specifications, formulation guides, and commercial quotes for our pediatric and neonatal animal health ingredients.
Contact us
© 2026 Jiangxi Serum Pharma Industries Co., Ltd. All Rights Reserved. Designed for Global Animal Health Excellence.
